Search - tctmd.com

Displaying 1 - 20 of 34

Sort: Relevancy | Date

News Conference News EuroPCR 2025

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

Michael O'Riordan

May 20, 2025

News Conference News EuroPCR 2024

FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI

Caitlin E. Cox

May 20, 2024

News Conference News EuroPCR 2024

Go Beyond Angiography in CCS to Pinpoint the Problem, Urges AID-ANGIO

Caitlin E. Cox

May 14, 2024

Presentation EuroPCR 2024

Diagnostic performance of fully automatic computational FFR in the CAREER study

Presenter: Shengxian Tu

May 14, 2024

Presentation EuroPCR 2024

Diagnostic accuracy of fully automatic Murray law-based quantitative flow ratio

Presenter: Shengxian Tu

May 14, 2024

Presentation EuroPCR 2024

Combining angiography and pre-specified intracoronary testing in patients with chronic coronary syndromes: the AID-ANGIO study

Presenter: Adrian Jeronimo

May 14, 2024

News Conference News EuroPCR 2020

Age May Impact Outcomes After PCI Choices Guided by FFR but Not iFR

Caitlin E. Cox

June 26, 2020

News Conference News EuroPCR 2019

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

Caitlin E. Cox

June 06, 2019

News Conference News EuroPCR 2019

Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION

L.A. McKeown

May 22, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Conference News EuroPCR 2018

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Michael O'Riordan

May 23, 2018

Presentation EuroPCR 2018

Five-year Outcomes with PCI Guided by Fractional Flow Reserve in Patients with Stable Coronary Artery Disease (FAME 2)

Presenter: Panagiotis Xaplanteris

May 23, 2018

Presentation EuroPCR 2018

FFR-guided PCI versus Medical Therapy to Reduce Cardiac Death or Myocardial Infarction

Presenter: Frederik M. Zimmermann

May 23, 2018

News Conference News EuroPCR 2018

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

Shelley Wood

May 22, 2018

News Conference News EuroPCR 2018

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

Caitlin E. Cox

May 22, 2018

Presentation EuroPCR 2018

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

Presenter: Rasha Al-Lamee

May 22, 2018

News Conference News EuroPCR 2018

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

Michael O'Riordan

May 22, 2018

Presentation EuroPCR 2017

Routine Fractional Flow Reserve Measurement after Percutaneous Coronary Intervention The FFR-SEARCH Study

Presenter: Roberto Diletti

May 18, 2017

News Conference News EuroPCR 2017

FFR-SEARCH Explores Potential of Physiologic Assessment After PCI

Caitlin E. Cox

May 18, 2017

Presentation EuroPCR 2017

Safety of Coronary Revascularisation Deferral Based on iFR and FFR Measurements in Stable Angina and Acute Coronary Syndromes

Presenter: Javier Escaned

May 17, 2017

Advertisement

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI

Go Beyond Angiography in CCS to Pinpoint the Problem, Urges AID-ANGIO

Diagnostic performance of fully automatic computational FFR in the CAREER study

Diagnostic accuracy of fully automatic Murray law-based quantitative flow ratio

Combining angiography and pre-specified intracoronary testing in patients with chronic coronary syndromes: the AID-ANGIO study

Age May Impact Outcomes After PCI Choices Guided by FFR but Not iFR

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Five-year Outcomes with PCI Guided by Fractional Flow Reserve in Patients with Stable Coronary Artery Disease (FAME 2)

FFR-guided PCI versus Medical Therapy to Reduce Cardiac Death or Myocardial Infarction

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

Routine Fractional Flow Reserve Measurement after Percutaneous Coronary Intervention The FFR-SEARCH Study

FFR-SEARCH Explores Potential of Physiologic Assessment After PCI

Safety of Coronary Revascularisation Deferral Based on iFR and FFR Measurements in Stable Angina and Acute Coronary Syndromes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content